• Study on Rivaroxaban, Dabigatran Etexilate, and Fluindione for Patients with Intra-Cardiac Thrombus

    Not recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia Germany Hungary Italy +6

  • Study on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Poland Spain

  • Study on Home Administration of Pertuzumab and Trastuzumab for Patients with Early or Locally Advanced HER2-Positive Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Spain

  • Study Comparing ACP-196 and Ibrutinib for Patients with High-Risk Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland Spain

  • Study on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study on the Safety and Effectiveness of Nirmatrelvir and Ritonavir for Nonhospitalized Children with COVID-19 at Risk of Severe Illness

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Hungary

  • Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Bulgaria France Germany Italy Poland +1

  • Study on Tolcapone for Improving Cognitive Symptoms in Patients with Long-Standing Schizophrenia

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of LB-100 plus doxorubicin compared to doxorubicin alone in adults with advanced soft tissue sarcomas as first-line treatment

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

powered by